Showing stories in Science. Select the same category pill again to clear the filter.

Scope
All World U.S. State Metro

Showing stories in U.S. scope. Select the same scope chip again to clear the filter.

Top Story

NASA Ends Maven Mission After Signal Loss

NASA declared the Maven spacecraft dead in June 2026 after it lost signal during a Mars occultation in December 2025. The probe’s fast rotation drained its batteries, making recovery impossible.
us Science

Rosenthal and Lu Develop Single-Cell Spatial Pharmacobiology Platform

Eben Rosenthal and Guolan Lu created a new platform called single-cell spatial pharmacobiology to visualize drug-tumor interactions in human solid tumors. The tool reveals how stromal barriers block therapeutic antibodies and helps distinguish between poor drug delivery and low biological activity.
us Science

Allen Institute Launches $400M Brain Health Accelerator

The Allen Institute launched a $400 million initiative to develop genetic therapies for neurodegenerative diseases. The effort will use human brain tissue and share data globally to enable precision treatments.
us Science

GLP-1 Drugs Linked to Lower Knee Replacement Risk

GLP-1 receptor agonists were tied to reduced long-term knee replacement risk in osteoarthritis patients. Researchers estimate thousands fewer surgeries yearly if eligible U.S. and U.K. patients used these medications for three years.
us Science

NSF Begins Descoping Ocean Observatories Initiative

The National Science Foundation has begun removing in-water infrastructure from the Ocean Observatories Initiative. Researchers warn the loss will hinder climate and ocean science for years to come.

Facts Desk

Explore all facts

Top in Science

View section
us Science

NASA Ends Maven Mission After Signal Loss

NASA declared the Maven spacecraft dead in June 2026 after it lost signal during a Mars occultation in December 2025. The probe’s fast rotation drained its batteries, making recovery impossible.
us Science

Rosenthal and Lu Develop Single-Cell Spatial Pharmacobiology Platform

Eben Rosenthal and Guolan Lu created a new platform called single-cell spatial pharmacobiology to visualize drug-tumor interactions in human solid tumors. The tool reveals how stromal barriers block therapeutic antibodies and helps distinguish between poor drug delivery and low biological activity.
us Science

Allen Institute Launches $400M Brain Health Accelerator

The Allen Institute launched a $400 million initiative to develop genetic therapies for neurodegenerative diseases. The effort will use human brain tissue and share data globally to enable precision treatments.
us Science

GLP-1 Drugs Linked to Lower Knee Replacement Risk

GLP-1 receptor agonists were tied to reduced long-term knee replacement risk in osteoarthritis patients. Researchers estimate thousands fewer surgeries yearly if eligible U.S. and U.K. patients used these medications for three years.